celecoxib has been researched along with Encephalitis in 5 studies
Encephalitis: Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of the present study was to examine whether celecoxib, a selective COX-2 inhibitor, can reduce systemic LPS-induced brain inflammation and brain damage." | 7.79 | Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats. ( Bhatt, AJ; Cai, Z; Fan, LW; Kaizaki, A; Numazawa, S; Pang, Y; Tanaka, S; Tien, LT, 2013) |
| " The objective of the present study was to examine whether celecoxib, a selective COX-2 inhibitor, can reduce systemic LPS-induced brain inflammation and brain damage." | 3.79 | Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats. ( Bhatt, AJ; Cai, Z; Fan, LW; Kaizaki, A; Numazawa, S; Pang, Y; Tanaka, S; Tien, LT, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Q | 1 |
| Dai, W | 1 |
| Chen, HY | 1 |
| Jacobs, RE | 1 |
| Zlokovic, BV | 1 |
| Lund, BT | 1 |
| Montagne, A | 1 |
| Bonnin, A | 1 |
| Fan, LW | 1 |
| Kaizaki, A | 1 |
| Tien, LT | 1 |
| Pang, Y | 1 |
| Tanaka, S | 1 |
| Numazawa, S | 1 |
| Bhatt, AJ | 1 |
| Cai, Z | 1 |
| Meinert, CL | 1 |
| McCaffrey, LD | 1 |
| Breitner, JC | 1 |
| Casolini, P | 1 |
| Catalani, A | 1 |
| Zuena, AR | 1 |
| Angelucci, L | 1 |
| Aid, S | 1 |
| Langenbach, R | 1 |
| Bosetti, F | 1 |
1 trial available for celecoxib and Encephalitis
| Article | Year |
|---|---|
Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Brain; Celecoxi | 2009 |
4 other studies available for celecoxib and Encephalitis
| Article | Year |
|---|---|
Prenatal disruption of blood-brain barrier formation via cyclooxygenase activation leads to lifelong brain inflammation.
Topics: Animals; Blood-Brain Barrier; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Encephalitis | 2022 |
Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Calcium-Binding Proteins; Celecoxib; Cell Death; Cycl | 2013 |
Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat.
Topics: Aging; Animals; Celecoxib; Cognition Disorders; Corticosterone; Cyclooxygenase 2; Cyclooxygenase 2 I | 2002 |
Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2.
Topics: Animals; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Ence | 2008 |